This topic contains a solution. Click here to go to the answer

Author Question: When blood enters the vast network of capillaries, called a(n) _____________, it is so dispersed ... (Read 80 times)

newbem

  • Hero Member
  • *****
  • Posts: 579
When blood enters the vast network of capillaries, called a(n) _____________, it is so dispersed that the rate of flow is reduced to a slow trickle, permitting time for O2 and nutrients to enter the tissue cells in exchange for CO2 and waste products.
 A) capillary bed
  B) vena cava
  C) arteriole branch
  D) infarction

Question 2

This device consists of a small battery-powered pulse generator with electrode catheters. The electrodes are inserted into a vein and threaded through the vena cava, one to the right atrium, the other into the right ventricle at the apex.
 A) artificial pacemaker
  B) stent
  C) angioplasty
  D) defibrillator



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Madisongo23

  • Sr. Member
  • ****
  • Posts: 325
Answer to Question 1

A

Answer to Question 2

A




newbem

  • Member
  • Posts: 579
Reply 2 on: Jun 25, 2018
Wow, this really help


miss_1456@hotmail.com

  • Member
  • Posts: 289
Reply 3 on: Yesterday
Excellent

 

Did you know?

The largest baby ever born weighed more than 23 pounds but died just 11 hours after his birth in 1879. The largest surviving baby was born in October 2009 in Sumatra, Indonesia, and weighed an astounding 19.2 pounds at birth.

Did you know?

Asthma occurs in one in 11 children and in one in 12 adults. African Americans and Latinos have a higher risk for developing asthma than other groups.

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

Carbamazepine can interfere with the results of home pregnancy tests. If you are taking carbamazepine, do not try to test for pregnancy at home.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library